The FDA granted accelerated approval to iberdomide plus daratumumab and hyaluronidase-fihj and dexamethasone for adults with relapsed multiple myeloma.
Want to know the latest news and articles posted on ONC?
Then subscribe to their feed now! You can receive their updates by email, via mobile or on your personal news page on this website.
See what they recently published below.
Website title: Oncologynewscentral.com